SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer
2019 · Journal of Hematology & Oncology · 121 citations
https://doi.org/10.1186/s13045-019-0700-2
S
Shuling Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
1.7K
Citations
21
h-index
37
i10-index
Shuling Zhou is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research. The author has an h-index of 21, co-authored 63 publications.
ORCID: 0000-0003-3408-9501Papers by this author
worksModelling the neuropathology of lysosomal storage disorders through disease-specific human induced pluripotent stem cells
2019 · Experimental Cell Research · 39 citations
https://doi.org/10.1016/j.yexcr.2019.04.021
Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation
2020 · Scientific Reports · 37 citations
https://doi.org/10.1038/s41598-020-60903-9
Role of BC040587 as a predictor of poor outcome in breast cancer
2014 · Cancer Cell International · 35 citations
https://doi.org/10.1186/s12935-014-0123-7
Impact of the Updated 2018 American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
2020 · Archives of Pathology & Laboratory Medicine · 18 citations
https://doi.org/10.5858/arpa.2019-0369-oa
HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
2023 · BMC Cancer · 14 citations
https://doi.org/10.1186/s12885-023-11134-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat